Systemic Connective Tissue Disorders: RA and SLE

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/24

flashcard set

Earn XP

Description and Tags

Vocabulary-style practice flashcards covering key definitions, clinical features, diagnostic markers, radiologic signs, and pharmacologic mechanisms for Rheumatoid Arthritis and Systemic Lupus Erythematosus based on lecture materials.

25 Terms

1
New cards

Connective Tissue Disorders (CTD)

A group of autoimmune, multisystem, chronic, inflammatory diseases driven by an antibody or T-cell response directed against self-antigens, leading to tissue damage and organ failure.

2
New cards

Rheumatoid Arthritis (RA)

A chronic systemic inflammatory disease of unknown etiology characterized primarily by bilateral symmetric polyarthritis (synovitis) affecting the hands and feet.

3
New cards
<p>Pannus</p>

Pannus

An exuberant proliferation and inflammation of the synovial membrane that leads to the destruction of articular tissues, including cartilage, bone, tendons, ligaments, and blood vessels.

4
New cards

Shared Epitope (RA Genetics)

A specific sequence motif in human leukocyte antigen (HLA)-DR4 and HLA-DR1 alleles that accounts for approximately 50% of the genetic risk for developing rheumatoid arthritis.

5
New cards

Felty Syndrome

A severe clinical triad variant of rheumatoid arthritis consisting of rheumatoid arthritis, splenomegaly, and neutropenia (leukopenia).

6
New cards

Rheumatoid Factor (RF)

An autoantibody, usually an IgM immunoglobulin, directed against the Fc fragment of IgG; it is present in roughly 60–80% of patients with rheumatoid arthritis.

7
New cards

Anti-Citrullinated Protein Antibodies (ACPA / Anti-CCP)

Highly specific diagnostic autoantibodies for rheumatoid arthritis that predict the radiographic progression of bone erosions independent of disease activity.

8
New cards

Lanoise Deformity

Fibular drift of the toes, a musculoskeletal deformity observed in the feet of patients with rheumatoid arthritis.

9
New cards
<p>Radiographic Hallmarks of RA</p>

Radiographic Hallmarks of RA

Characteristic plain X-ray findings in rheumatoid arthritis including soft tissue swelling, periarticular osteopenia, joint space narrowing, and marginal erosions.

10
New cards

Methotrexate (MTX)

A conventional synthetic DMARD that inhibits dihydrofolate reductase to decrease folate-dependent DNA/RNA synthesis and increase anti-inflammatory adenosine levels.

11
New cards

Leflunomide

A DMARD that inhibits dihydroorotate dehydrogenase, blocking pyrimidine synthesis and thereby inhibiting T and B cell proliferation.

12
New cards

Sulfasalazine

A DMARD converted to 5-ASA in the colon that exerts anti-inflammatory action by inhibiting NF-κ\kappaB and cytokine production.

13
New cards

Hydroxychloroquine (HCQ)

An antimalarial DMARD that increases lysosomal pH to inhibit antigen presentation; recommended for all SLE patients at doses ≤5 mg/kg/day\le 5\,\text{mg/kg/day}.

14
New cards

Mycophenolate Mofetil (MMF)

An immunosuppressive cell-cycle inhibitor that blocks inosine monophosphate dehydrogenase, selectively inhibiting de novo purine synthesis in lymphocytes.

15
New cards

Cyclophosphamide

An alkylating agent that cross-links DNA to inhibit rapidly dividing B and T lymphocytes, used for organ-threatening manifestations in connective tissue diseases.

16
New cards

Tocilizumab

A biologic DMARD that inhibits IL-6-mediated signaling and inflammation by blocking both soluble and membrane-bound IL-6 receptors.

17
New cards

Tofacitinib

A targeted synthetic DMARD (tsDMARD) that inhibits Janus kinases (JAK1/JAK3) to block the intracellular signaling pathways of multiple cytokines.

18
New cards

Systemic Lupus Erythematosus (SLE)

A chronic multisystem autoimmune disease characterized by autoantibodies against nuclear and cytoplasmic antigens, predominantly affecting women of childbearing age (female-to-male ratio of 11:1).

19
New cards
<p>Malar Rash</p>

Malar Rash

An erythematous cutaneous lesion characteristically appearing over the cheeks and nasal bridge while sparing the nasolabial folds, seen in acute cutaneous lupus.

20
New cards

Subacute Cutaneous Lupus

A dermatologic manifestation of SLE presenting as annular or psoriasiform patches with crusted margins, typically occurring on sun-exposed areas of the limbs or torso.

21
New cards

Libman-Sacks Endocarditis

A noninfectious form of endocarditis characterized by sterile valvular vegetations in patients with systemic lupus erythematosus.

22
New cards

Antinuclear Antibodies (ANA)

The essential screening entry criterion for EULAR/ACR SLE classification (titer ≥1:80\ge 1:80 on HEp-2 cells), possessing approximately 95% sensitivity for SLE.

23
New cards

Anti-dsDNA Antibodies

Highly specific autoantibodies for SLE (sensitivity ~70%) whose serum levels fluctuate parallel to underlying clinical disease activity.

24
New cards

Anti-Sm Antibodies

The most specific autoantibody marker for systemic lupus erythematosus, present in approximately 30–40% of SLE patients.

25
New cards

Synovial Fluid Analysis in RA

Laboratory evaluation of joint fluid revealing inflammatory counts (WBC 2,000–50,000/μL\mu\text{L}) with 60–80% neutrophil predominance and characteristically low glucose levels relative to serum.